ChemComm
Communication
In summary, these results describe the efficient synthesis of
the novel maltol-derived hydrazide 6 and its attachment to two
different cancer cell lines. Preliminary experiments show that
multicellular aggregation can be selectively achieved with Fe3+
ions, even in the presence of other ions, generating 3D aggre-
gates on demand which could find various applications.
Although cancer cells were used in this study, this approach
could be applied to any cell type possessing sialic acid residues
on the surface. It could be used with cells which do not naturally
aggregate or to template layers of different cells to create
predictable multicellular structures for use in tissue engineering.
We are grateful to the University of Bath for providing a
studentship for AC and also wish to acknowledge RCUK and the
University of Bath for the fellowship to LC.
Fig. 3 Optical density of MTS assays with unmodified and maltol-modified
HT29 cells in the absence (white/black) and presence (shaded) of 50 mM Fe3+
after 24, 48 and 72 h incubation. Data shown as mean Æ standard error of three
independent experiments.
Notes and references
1 R. Langer and J. P. Vacanti, Science, 1993, 260, 920–926.
2 D. Yip and C. H. Cho, Biochem. Biophys. Res. Commun., 2013, 433,
327–332.
3 W. G. Dai, J. Belt and W. M. Saltzman, Bio/Technology, 1994, 12,
797–801.
4 P. A. De Bank, B. Kellam, D. A. Kendall and K. M. Shakesheff,
Biotechnol. Bioeng., 2003, 81, 800–808.
aggregates observed after 20 min, with no aggregation apparent in
the presence of Ru3+, Cu2+ or Zn2+ under the same conditions. The
addition of potent Fe-chelators, such as EDTA or maltol 1 itself, to
established aggregates did not reverse the process and aggregates
appeared to be unaffected.
5 P. A. De Bank, Q. Hou, R. M. Warner, I. V. Wood, B. E. Ali,
S. MacNeil, D. A. Kendall, B. Kellam, K. M. Shakesheff and L. D. K.
Buttery, Biotechnol. Bioeng., 2007, 97, 1617–1625.
6 D. Zhao, S.-M. Ong, Z. Yue, Z. Jiang, Y.-C. Toh, M. Khan, J. Shi,
C.-H. Tan, J. P. Chen and H. Yu, Biomaterials, 2008, 29, 3693–3702.
7 Z. J. Gartner and C. R. Bertozzi, Proc. Natl. Acad. Sci. U. S. A., 2009,
106, 4606–4610.
8 N. Kojima, S. Takeuchi and Y. Sakai, Biomaterials, 2011, 32, 6059–6067.
9 K. Y. Lee and D. J. Mooney, Chem. Rev., 2001, 101, 1869–1879.
10 M. M. Pires and J. Chmielewski, J. Am. Chem. Soc., 2009, 131, 2706–2712.
11 M. M. Pires, D. E. Przybyla and J. Chmielewski, Angew. Chem., Int.
Ed., 2009, 48, 7813–7817.
To examine the effects of maltol modification and exposure to
Fe3+ on cell proliferation, modified MTS assays were performed and
readings taken at 24, 48 and 72 h (Fig. 3). After 24 h, the optical
density (OD) reading for the unmodified cells and maltol-modified
cells were all comparable, both in the absence and presence of
50 mM Fe3+. This data suggests that cells modified with the maltol-
derived hydrazide are viable and, in addition, that the presence of
50 mM Fe3+ in both cell types did not have a detrimental effect.
Similar results were also observed after 48 and 72 h.
12 D. T. LeBlanc and H. A. Akers, Food Technol., 1989, 43, 78–84.
13 K. H. Thompson, C. A. Barta and C. Orvig, Chem. Soc. Rev., 2006, 35,
545–556.
The effects of cell aggregation using two different cell types was
also examined, using human colon carcinoma (HT29) and human
breast carcinoma (MDA-MB-231) cell lines functionalised with the 14 P. S. Dobbin, R. C. Hider, A. D. Hall, P. D. Taylor, P. Sarpong,
J. B. Porter, G. Xiao and D. van der Helm, J. Med. Chem., 1993, 36,
maltol-derived hydrazide 6. To visually differentiate the cell types,
2448–2458.
HT29 and MDA-MB-231 cells were fluorescently labelled green and
15 B. L. Rai, L. S. Dekhordi, H. Khodr, Y. Jin, Z. Liu and R. C. Hider,
red respectively using CellTrackert. The addition of 50 mM Fe3+ to
the labelled maltol-modified cells led to the formation of hetero-
cellular aggregates shown in Fig. 4. The HT29 (green) and MDA-MB-
J. Med. Chem., 1998, 41, 3347–3359.
16 R. C. Hider, Z. D. Liu and S. Piyamongkol, Transfus. Sci., 2000, 23,
201–209.
17 Z. D. Liu and R. C. Hider, Coord. Chem. Rev., 2002, 232, 151–171.
231 (red) cells appear randomly arranged within the aggregate giving 18 Z. D. Liu and R. C. Hider, Med. Res. Rev., 2002, 22, 26–64.
19 T. Zhou, Y. Ma, X. Kong and R. C. Hider, Dalton Trans., 2012, 41,
areas of yellow, resulting from the overlap of red and green cells.
6371–6389.
This result is of particular note as it demonstrates that modifying
20 T. Zhou, G. Winkelmann, Z. Y. Dai and R. C. Hider, J. Pharm.
the cell surface with the maltol-derivative 6 and aggregation in the
presence of Fe3+ can be applied to different cell types. Further studies
will investigate possible self-organisation of heterocellular aggregates
as reported by Kojima.8
Pharmacol., 2011, 63, 893–903.
21 L. S. Dehkordi, Z. D. Liu and R. C. Hider, Eur. J. Med. Chem., 2008,
43, 1035–1047.
22 S. Amatori, I. Bagaloni, E. Macedi, M. Formica, L. Giorgi, V. Fusi and
M. Fanelli, Br. J. Cancer, 2010, 103, 239–248.
23 S. Amatori, G. Ambrosi, M. Fanelli, M. Formica, V. Fusi, L. Giorgi,
E. Macedi, M. Micheloni, P. Paoli, R. Pontellini and P. Rossi, J. Org.
Chem., 2012, 77, 2207–2218.
24 G. A. Lemieux and C. R. Bertozzi, Trends Biotechnol., 1998, 16, 506–513.
25 A. H. Cory, T. C. Owen, J. A. Barltrop and J. G. Cory, Cancer Commun.,
1991, 3, 207–212, MTS is 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxy-
methoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium.
26 K. E. Norgard, H. Han, L. Powell, M. Kriegler, A. Varki and
N. M. Varki, Proc. Natl. Acad. Sci. U. S. A., 1993, 90, 1068–1072.
27 G. Papanikolaou and K. Pantopoulos, Toxicol. Appl. Pharmacol.,
2005, 202, 199–211.
Fig. 4 Representative fluorescence images of maltol-modified HT29 cells
(green, B) and MDA-MB-231 cells (red, C) in the presence of 50 mM Fe3+ after
20 min incubation. Scale bars = 200 mm and the results are typical of three
independent experiments.
28 S. V. Torti and F. M. Torti, Nat. Rev. Cancer, 2013, 13, 342–355.
29 D. C. Kennedy, B. O. Patrick and B. R. James, Can. J. Chem., 2011, 89,
948–958.
c
10150 Chem. Commun., 2013, 49, 10148--10150
This journal is The Royal Society of Chemistry 2013